BioPharma & Healthcare Related News

Illumina Ventures Closes $230 Million Fund

Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health San Francisco – Oct. 16, 2017 – Illumina Ventures, an independent, early-stage venture capital firm, announced today that it has raised $230 million [...]

By | October 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections

Collaboration with Roche Deploys Warp Drive’s Proprietary Genome Mining™ Platform to Discover Multiple Novel Classes of Antibiotics Warp Drive to Receive up to $387 Million in Upfront Fees and Milestone Payments Roche Gaining Worldwide Rights to Advance Certain Antibiotic [...]

By | October 17th, 2017|BioPharma & Healthcare, News, Therapeutics|

Codexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership

Includes an option for the global development of CDX-6114 for PKU, marking Codexis’ first partnership for an internally developed biotherapeutic product.  Codexis receives an upfront payment of $14 million and potential milestones and royalties depending on product success In addition, the partnership adds [...]

By | October 13th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 10, 2017-- Synlogic (Nasdaq: SYBX) announced the addition of two experienced executives to key leadership roles: Andrew Gengos as Chief Operating Officer and Head of Corporate Development, and Adam Thomas as Chief Human Resources Officer. “We are very pleased to welcome Andrew [...]

By | October 11th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer

ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 02, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, announced today that Dr. Samarth Kulkarni, Ph.D., currently President of CRISPR Therapeutics, Inc., has been promoted to the role of Chief Executive [...]

By | October 2nd, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal Study

First-in-class, one-year data demonstrate sustained TTR protein reduction of approximately 97 percent, corresponding to 70 percent liver editing, following a single in vivo systemic dose in mice Non-human primate studies ongoing and leading to development candidate designation in first [...]

By | September 30th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|